Fig. 4
From: Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancer
ROC curves of the CLI, TCMF2, TACS + TCMF1, TACS + TCFM1 + TCMF2, and CLI + TACS + TCMF1 + TCMF2 models predicting 5-year DFS in the training, internal validation, and external validation cohort.
